New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade

The new Tema Cardiovascular and Metabolic ETF fell in its first day of trade. It is exposed to weight-loss drugs including Ozempic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.